Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Quy Trình Đánh Giá Và Xử Trí TTHKTM Ở Bệnh Nhân Sản Khoa Theo Hướng Dẫn Điều Trị Của Bộ Y Tế 2023

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Half-life extension with Fc-fusion

Watch a 3-minute animated video explaining the mechanism of action (MOA) for extended half-life Fc-fusion factor replacement therapies.